HALEF OKAN DOĞAN, Sibel BERKSOY HAYTA

Chitotirosidase and prolidase in tinea pedis: A preliminary study

Dermatophyte infections are superficial fungal infections. Tinea pedis is a dermatophyte infection of the feet and interdigital spaces. An evaluation was made of the chitotriosidase (ChT) concentrations, prolidase activity and the possible association between these biomarkers in tinea pedis. Study subjects were comprised of 42 patients with tinea pedis and 40 healthy subjects. Serum ChT concentrations and prolidase activity were determined in study population. Higher ChT concentrations were found in patients than controls (p < 0.001). We did not find any difference between groups in terms of prolidase activity (p = 0.162). We also did not found any correlation between ChT and prolidase activity. ChT seems to have roles during the inflammatory conditions in patients with tinea pedis. Whereas prolidase activity is not associated with the tinea pedis.

PDF

___

Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008;166(5-6):335-52.

Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374-88.

Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev. 1995;8(3):317-35.

Brasch J. Current knowledge of host response in human tinea. Mycoses. 2009;52:304-12.

Brasch J. Pathogenesis of tinea. JDDG. 2010:8;780–6.

Alanbay I, Ercan CM, Sakinci M, Coksuer H, Ozturk M, Tapan S. A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity? Arch Gynecol Obstet. 2012;286(4):1065-71.

Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, Hollak CE, Aerts JM, Galjaard H, vanDiggelen OP. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis. 1995;18(6):717–22.

Boot RG, Hollak CE, Verhoek M, Alberts C, Jonkers RE, Aerts JM. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis. Clin Chim Acta. 2010;411(1-2):31–6.

Coskun O, Ozturk M, Erdem H, Gumral R, Yaman H, Karakas A, Kilic S, Eyigun CP. Can chitotriosidase be a surrogate marker for invasive fungal disease? J Mycol Med. 2012;22(3):256-60.

Labadaridis I, Dimitriou E, Theodorakis M, Kafalidis G, Velegraki A, Michelakakis H. Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child Fetal and Neonatal Edt. 2005;90(6):531-2.

Nasser HA, Rajab M, Tanios BY. Massive splenomegaly secondary to prolidase deficiency. Am J Med Sci. 2015;349(2):169.

Butbul Aviel Y, Mandel H, Avitan Hersh E, Bergman R, Adiv OE, Luder A, Brik R. Prolidase deficiency associated with systemic lupus erythematosus (SLE): single site experience and literature review. Pediatr Rheumatol Online J. 2012;22(10):18.

Mandel H, Abeling N, Gutman A, Berant M, Scholten EG, Sheiman C, Luder A, van Gennip AH. Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis. Prenat Diagn. 2000;20(11):927–9.

Cleary MA, Heaney M, Couriel JM, Walter JH. Immune function in prolidase deficiency. J Inherit Metab Dis. 1994;17(3):345–8.

Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidaseactivity:A possible index of collagen catabolism in chronic liver disease. Clin Chem. 1984;30(2):211–5.

Myara I, Charpentier C, Lemonnier A. Optimal conditions forprolidase assay by proline colorimetric determination: Applicationtoiminodipeptiduria. Clin Chim Acta. 1982;125(2):193–205.

James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Ohta S, Izuhara K, Bel E, Kere J, Söderhäll C, Dahlén B, Boot RG, Dahlén SE; BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium.. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2016;193(2):131-42.

Di Rosa M, Malaguarnera L. Chitotriosidase: A New Inflammatory Marker in Diabetic Complications. Pathobiology. 2016;83(4):211-9.

Chiarla C, Giovannini I, Antuzzi D, Piras A, Ardito F, Giuliante F. Clinical use of plasma chitotriosidase in severe sepsis. Curr Med Res Opin. 2016;32(2):273-6.

Vega K, Kalkum M. Chitin, Chitinase Responses, and Invasive Fungal Infections. International Journal of Microbiology. 2012;2012:920459.

Masoud M, Rudensky B, Elstein D, Zimran A. Chitotriosidase deficiency in survivors of Candida sepsis. Blood Cells Mol Dis. 2002;29(1):116-8.

Gordon-Thomson C, Kumari A, Tomkins L, Holford P, Djordjevic JT, Wright LC, Sorrell TC, Moore GP. Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci. 2009;66(6):1116-25.

Overdijk B, Van Steijn GJ, Odds FC. Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus. Glycobiology. 1996;6(6):627-34.

Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev. 1995;8(3):317-35.

Kanneganti M, Kamba A, Mizoguchi E. Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol. 2012;5:1-9.

Barreto-Bergter E, Figueiredo RT. Fungal glycans and the innate immune recognition. Front Cell Infect Microbiol. 2014;4:145.

Kougias P, Wei D, Rice PJ, Ensley HE, Kalbfleisch J, Williams DL, Browder IW. Normal human fibroblasts express pattern recognition receptors for fungal(1-3)-beta-D-glucans. Infect Immun. 200;69(6):3933-8.

Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica. 1994;79(1):13-8.

Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 2008;35(4):731-8.

Wei D, Zhang L, Williams DL, Browder IW. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism. Wound Repair Regen. 2002;10(3):161-8.